Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.23.2
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Jul. 28, 2023
Apr. 24, 2023
Feb. 10, 2023
Jul. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 13, 2023
Apr. 30, 2023
Feb. 28, 2023
Subsequent Events                  
Repayments of debt         $ 40,375 $ 0      
Stock offering, price per share                 $ 5.25
Exercise price of warrants             $ 0.5424    
Proceeds from issuance of Common stock         1,168 $ 5,527      
Direct Offering [Member]                  
Subsequent Events                  
Stock offering, price per share     $ 0.835            
Proceeds from issuance of Common stock     $ 13,200            
Pre-Funded Warrants [Member]                  
Subsequent Events                  
Stock offering, price per share                 $ 5.2499
UBriGene                  
Subsequent Events                  
Bookvalue of lease liability         $ 3,800        
Aevitas | Asset purchase agreement to acquire Aevitas proprietary rights | Maximum                  
Subsequent Events                  
Asset Purchase Agreement Upfront Payment To Be Made   $ 140,000              
Checkpoint | Direct Offering [Member]                  
Subsequent Events                  
Exercise price of warrants               $ 3.35  
Checkpoint | Series A Warrants [Member]                  
Subsequent Events                  
Warrant expiration term               5 years  
Checkpoint | Series B Warrants [Member]                  
Subsequent Events                  
Warrant expiration term               18 months  
Subsequent events | East West Bank ("EWB Loan") [Member]                  
Subsequent Events                  
Repayments of debt       $ 10,000          
Subsequent events | UBriGene                  
Subsequent Events                  
Consideration Transferred $ 6,000                
Contingent liability $ 5,000                
Contingent consideration period 2 years                
Contingent liability, Issuance of equity securities $ 10,000                
Contingent consideration, Proposed lease period 2 years                
Bookvalue of lease liability $ 3,800                
Subsequent events | Checkpoint | Direct Offering [Member]                  
Subsequent Events                  
Shares issued       2,427,186          
Stock offering, price per share       $ 3.09          
Proceeds from issuance of Common stock       $ 10,000          
Net proceeds       9,100          
Stock offering other fees paid       $ 900          
Subsequent events | Checkpoint | Series A Warrants [Member] | Direct Offering [Member]                  
Subsequent Events                  
Number of warrants to purchase shares       3,236,248          
Warrant expiration term       5 years          
Exercise price of warrants       $ 2.84          
Subsequent events | Checkpoint | Series B Warrants [Member] | Direct Offering [Member]                  
Subsequent Events                  
Number of warrants to purchase shares       3,236,248          
Warrant expiration term       18 months          
Exercise price of warrants       $ 2.84          
Subsequent events | Checkpoint | Pre-Funded Warrants [Member] | Direct Offering [Member]                  
Subsequent Events                  
Shares issued       809,062          
Stock offering, price per share       $ 3.0899